CRISPR/Cas9 technology generated an glutamate to lysine substitution at amino acid 896 (p.E896K). This mimics the human focal segmental glomerulosclerosis (FSGS) disease associated mutation E897K and is a gain-of-function allele. (J:334958)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count